Amber (@EpiAmber) header
Amber (@EpiAmber) profile picture

Infectious Disease Epidemiologist @JohnsHopkinsSPH. Interested in translational epidemiology, infectious disease. Views are solely my own.

Baltimore, MD
Joined October 2019
Photo by Amber (@EpiAmber)Photo by Amber (@EpiAmber)Photo by Amber (@EpiAmber)Photo by Amber (@EpiAmber)Photo by Amber (@EpiAmber)
Was wonderful to meet in person for the the Eurogin 2022 conference. Lucky to have colleagues like @hilaryarobbins @DrKKuhs @EleniRettig as fellow speakers for this head and neck cancer session
2
8
See our press briefing discussing BA2 variant, what is to come in year three of the pandemic and how violence in Ukraine increases COVID-19 transmission youtu.be/22jy8H5jxyQ via @YouTube
Enjoyed speaking with @FUTURUMCareers about epidemiology, my research journey and amazing collaborators. Lots of opportunities for young people interested in making a difference in public health.
Professor Amber D’Souza, based @JohnsHopkinsSPH in the US, is working to develop improved means of detecting oral HPV16 infection. The findings could help detect oropharyngeal cancers caused by HPV earlier and reduce cancer incidence futurumcareers.com/hpv16-and…
2
5
Nice job by @AACR on this summary of impacts of COVID on cancer. Includes patient perspective video and infographics that drive home how far we have come and how the past two years impacted many living with cancer. aacr.org/professionals/resea…
5
"Going out and intentionally seeking this infection does not serve the purpose of getting it over with," says @EpiAmber. "It doesn’t protect you long term from infection, because those antibodies from getting COVID don’t last that long." fox10phoenix.com/news/trend-…
3
3
This was an interesting chat I had with @EpiAmber and @DavidWDowdy about how what we know about herd immunity doesn't seem to apply to #COVID19. Take a listen.
It will be very challenging to get to the level of population immunity against COVID-19 that we have seen with measles in the U.S., explain epidemiologists @EpiAmber and @DavidWDowdy on today's episode. 🎧 johnshopkinssph.libsyn.com/3…
9
19
So proud of my graduate student @YuehanZhang2 for this wonderful analysis on Expect impact of HPV Vaccination on Oropharynx Cancer Incidence, 2020-2045 ja.ma/38AqNwx via @JAMAOnc part of @JAMANetwork
2
1
1
8
"If we don't get high [vaccine] uptake among all groups, we're not going to be able to reduce transmission," cautioned @EpiAmber. wapo.st/3za7XZr
11
8
Thrilled our paper on household #COVID19 risk and in person schooling is out in @ScienceMagazine rapid release! science.sciencemag.org/conte… w/ MK Grabowski, @andrewazman, @khgrantz, @Lizstuartdc, @CJEMetcalf et al. Some highlights (repetatuve w/ nitter.cf/JustinLessler/status/1… ) (1/n)
11
66
23
175
See our video on @FacebookWatch about "How Close Are We to Herd Immunity With Vaccine Rollouts?" fb.watch/4KTfwl55iZ/
1
We updated our article on Herd Immunity and how we can achieve it. This is a race of vaccine verse virus, but we can win that race. jhsph.edu/covid-19/articles/…
18
26
This week's upcoming Dean's Lecture with @EpiAmber will focus on translational epidemiology, or using epidemiological results to improve health outcomes and help shape policies—quite a timely topic. Mark your calendars! 📅 March 10 🕙 4-5pm EST 🔗 jh.zoom.us/webinar/register/…
4
14
BREAKING—Single-shot Johnson & Johnson vaccine was 72 % effective at protecting against moderate to severe illness in US, 66 % effective in Latin America & 57 % effective in South Africa. It was 85 % effective overall at preventing severe disease. #COVID19 washingtonpost.com/health/20…
152
1,315
268
3,212